1. Home
  2. IRIX vs RGNT Comparison

IRIX vs RGNT Comparison

Compare IRIX & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$0.99

Market Cap

23.2M

Sector

Health Care

ML Signal

HOLD

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$3.02

Market Cap

20.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IRIX
RGNT
Founded
1989
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.2M
20.4M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
IRIX
RGNT
Price
$0.99
$3.02
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
48.7K
4.8K
Earning Date
03-26-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
8.47
N/A
EPS
N/A
N/A
Revenue
$41,593,000.00
N/A
Revenue This Year
$10.43
N/A
Revenue Next Year
$7.32
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.79
$2.80
52 Week High
$1.65
$8.35

Technical Indicators

Market Signals
Indicator
IRIX
RGNT
Relative Strength Index (RSI) 23.19 34.11
Support Level $0.87 N/A
Resistance Level $1.22 $3.38
Average True Range (ATR) 0.07 0.16
MACD -0.03 0.08
Stochastic Oscillator 8.43 37.92

Price Performance

Historical Comparison
IRIX
RGNT

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate (a polymer involved in tissue engineering) and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: